Substrate
Topic

nektar-therapeutics

1 stories related to this topic, newest first.

Law Firm Reminds Nektar Therapeutics Investors of Lead Plaintiff Deadline in Securities Class Actionbenzinga.com
finance46 days ago

Law Firm Reminds Nektar Therapeutics Investors of Lead Plaintiff Deadline in Securities Class Action

A law firm has issued a reminder for investors in Nektar Therapeutics who purchased securities during a specified period to file a lead plaintiff motion by May 5, 2026. The class action relates to a clinical trial failure announced in December 2025 that led to a stock price decli…

Benzinga
1 source